These results indicated that the function of CCR7 as an inhibitor on apoptosis of the NSCLC cells is predominantly implemented possibly by the pathways of bcl-2, bax, and caspase-3 but not p53. This evidence concerns the gene CCR7 and non-small cell lung carcinoma.